Semaglutide: selected references HeartPep literature library, reviewed 2026-11-20 https://heartpep.com/us/research/library/semaglutide 1. Wilding JPH, Batterham RL, Calanna S, et al.; STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine. DOI: https://doi.org/10.1056/NEJMoa2032183 PMID: 33567185 Source: https://pubmed.ncbi.nlm.nih.gov/33567185/ Verification: Abstract / bibliographic record. 2. Aronne LJ, Horn DB, le Roux CW, et al.; SURMOUNT-5 Trial Investigators (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity New England Journal of Medicine. DOI: https://doi.org/10.1056/NEJMoa2416394 PMID: 40353578 Source: https://pubmed.ncbi.nlm.nih.gov/40353578/ Verification: Abstract / bibliographic record. 3. Wilding JPH, Batterham RL, Davies M, et al.; STEP 1 Study Group (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension Diabetes, Obesity and Metabolism. DOI: https://doi.org/10.1111/dom.14725 PMID: 35441470 Source: https://pubmed.ncbi.nlm.nih.gov/35441470/ Verification: Abstract / bibliographic record. 4. University of Minnesota (sponsor) (2026). Lifestyle Counseling and Medication for Adolescent Weight Management (NCT04873245) ClinicalTrials.gov registry results. Source: https://clinicaltrials.gov/study/NCT04873245?tab=results Verification: Abstract / bibliographic record. 5. Wharton S, Broholm C, Horn D, et al. (2026). Efficacy and safety of co-administered cagrilintide-semaglutide (CagriSema) 1·7 mg each and 1·0 mg each in adults with overweight or obesity (REDEFINE 9): a multicentre, randomised, double-blind within-dose-level, placebo-controlled, parallel-group, phase 3b trial The Lancet Diabetes & Endocrinology. DOI: https://doi.org/10.1016/S2213-8587(26)00275-5 PMID: 43033821 Source: https://www.sciencedirect.com/science/article/pii/S2213858726002755 Verification: Abstract / bibliographic record. 6. Borlaug BA, Jensen MD, Packer M, et al. (2026). Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial Nature Medicine. DOI: https://doi.org/10.1038/s41591-026-04762-3 PMID: 43000472 Source: https://www.nature.com/articles/s41591-026-04762-3 Verification: Abstract / bibliographic record. 7. Marx N, Deanfield JE, Mulvagh SL, et al. (2026). First and Subsequent Major Cardiovascular Events With Oral Semaglutide in High-Risk Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial JAMA Cardiology. DOI: https://doi.org/10.1001/jamacardio.2026.4944 PMID: 43013292 Source: https://jamanetwork.com/journals/jamacardiology/fullarticle/2856457 Verification: Full text. 8. Chan E, Zabek M, Balluku A, et al. (2026). Evaluation of semaglutide in an ex vivo human placental perfusion model to estimate maternal-fetal transfer Placenta. DOI: https://doi.org/10.1016/j.placenta.2026.11.007 PMID: 43025349 Source: https://pubmed.ncbi.nlm.nih.gov/43025349/ Verification: Abstract / bibliographic record. 9. Kloock S, Zytner P, Geiger N, et al. (2026). Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats Bone. DOI: https://doi.org/10.1016/j.bone.2026.118170 PMID: 43025770 Source: https://pubmed.ncbi.nlm.nih.gov/43025770/ Verification: Abstract / bibliographic record. 10. Aubrac G et al. (2026). Cardiovascular Outcomes in Semaglutide Versus Tirzepatide Users With Obesity and Atherosclerotic Disease: A Target Trial Emulation Diabetes, Obesity and Metabolism. DOI: https://doi.org/10.1111/dom.71550 PMID: 43010688 Source: https://pubmed.ncbi.nlm.nih.gov/43010688/ Verification: Abstract / bibliographic record. 11. Doma M et al. (2026). Cardiovascular outcomes with semaglutide versus tirzepatide in patients with obesity and atherosclerotic cardiovascular disease without diabetes American Heart Journal Plus: Cardiology Research and Practice. DOI: https://doi.org/10.1016/j.ahjo.2026.101003 PMID: 43022342 Source: https://www.sciencedirect.com/science/article/pii/S2666602226002934 Verification: Abstract / bibliographic record. These are selected background references, not evidence that a HeartPep product or batch matches a studied preparation. Cite and assess the original papers.